Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Intranasal administration of cold-adapted live-attenuated SARS-CoV-2 candidate vaccine confers protection against SARS-CoV-2

9 Jul 2022

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Animal Virus Infections Studies
Share to COVID-19 Clinical Research Studies
Share to SARS-CoV-2 and COVID-19 Research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 35820511
DOI: 10.1016/j.virusres.2022.198857

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Intranasal administration of cold-adapted live-attenuated SARS-CoV-2 candidate vaccine confers protection against SARS-CoV-2PMID 35820511Read ↗

Cold-Adapted Live Attenuated SARS-Cov-2 Vaccine Completely Protects Human ACE2 Transgenic Mice from SARS-Cov-2 InfectionSemantic proximity Read ↗

A single-dose live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidateSemantic proximity Read ↗

The Cold-Adapted, Temperature-Sensitive SARS-CoV-2 Strain TS11 Is Attenuated in Syrian Hamsters and a Candidate Attenuated VaccineSemantic proximity Read ↗

Versatile live-attenuated SARS-CoV-2 vaccine platform applicable to variants induces protective immunitySemantic proximity Read ↗

Vaccine-induced CD8+ T cells are key to protection from SARS-CoV-2Semantic proximity Read ↗

Minimal change disease relapse following SARS-CoV-2 mRNA vaccineSemantic proximity Read ↗

A conserved subunit vaccine designed against SARS-CoV-2 variants showed evidence in neutralizing the virusSemantic proximity Read ↗

Safety and immunogenicity of anti-SARS-CoV-2 heterologous scheme with SOBERANA 02 and SOBERANA Plus vaccines: Phase IIb clinical trial in adultsSemantic proximity Read ↗

Development of safe and highly protective live-attenuated SARS-CoV-2 vaccine candidates by genome recoding.Semantic proximity Read ↗

Design of a peptide-based subunit vaccine against novel coronavirus SARS-CoV-2Semantic proximity Read ↗

Viral Live‐Attenuated Vaccines (LAVs): Past and Future DirectionsSemantic proximity Read ↗

Preclinical Evaluation of a Newcastle Disease Virus-Vectored Intranasal SARS-CoV-2 VaccineSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.